Phospholipase A2 stimulates rat gastric epithelial cell line (RGM-1) migration

Inflammation Research

Volumn 46, Issue 3, 1997, Pages 103-107

  Minami, T ^a   Tojo, H ^a   Zushi, S ^a   Shinomura, Y ^a   Matsuzawa, Y ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Epithelial migration; Lysophospholipids; Phospholipase A2; Phospholipids

Indexed keywords

4 BROMOPHENACYL BROMIDE; ENZYME INHIBITOR; LIPOXYGENASE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLSERINE; MITOMYCIN C; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASE A2; PIROXICAM; PROSTAGLANDIN SYNTHASE; 4-BROMOPHENACYL BROMIDE; ACETOPHENONE DERIVATIVE; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A; PROSTAGLANDIN SYNTHASE INHIBITOR; WE 201;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; EPITHELIUM CELL; NONHUMAN; PHOSPHOLIPID METABOLISM; RAT; STOMACH EPITHELIUM; WOUND HEALING; ANIMAL; CELL LINE; CELL MOTION; DRUG ANTAGONISM; DRUG SCREENING; INJURY; STIMULATION; STOMACH MUCOSA;

ACETOPHENONES; ANIMALS; CELL LINE; CELL MOVEMENT; CYCLOOXYGENASE INHIBITORS; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; GASTRIC MUCOSA; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; NORDIHYDROGUAIARETIC ACID; PHOSPHOLIPASES A; PIROXICAM; RATS; STIMULATION, CHEMICAL;

EID: 0030612068     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050119     Document Type: Article

References (13)

1. Kudo I, Murakami M, Hara S, Inoue K. Mammalian nonpancreatic phospholipase A2. Biochim Biophys Acta 1993;117: 213-31.
2. Minami T, Tojo H, Shinomura Y, Tarai S, Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II phospholipase A2: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992;33:914-21.
3. Minami T, Tojo H, Shinomura Y, Komatsubara T, Matsuzawa Y, Okamoto M. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol 1993;88:1076-80.
4. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M. Increased group II phospholipase A2 in colonie mucosa of patients with Crohn's disease and ulcerative colitis. Gut 1994;35:1593-8.
5. Vadas P, Pruzanski W, Kim J, Fornasier V. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol 1989;134:807-11.
6. Rutten MJ, Ito S. Morphology and electrophysiology of guinea pig gastric mucosal repair in vitro. Am J Physiol 1993;244:G171-83.
7. Silen W. Gastric mucosal defense and repair. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 2nd ed. New York: Raven Press, 1987:1055-69.
8. Silen W, Ito S. Mechanism for rapid-epithelialization of the gastric mucosal surface. Annu Rev Physiol 1985;47:217-29.
9. Sato Y, Rifkin DP. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of latent transforming growth factor β1 like molecules by plasmin during coculture. J Cell Biol 1989;109:309-15.
10. Radin NS. Extraction of tissue lipids with a solvent of low toxicity. Meth Enzymol 1981;72:5-7.
11. Vaskovsky VE, Kostetsky EY, Vasendin IM. A universal reagent for phospholipid analysis. J Chromatogr 1975;114:129-41.
12. Joyc NC, Meklir B. PGE2: a modulator of corneal endothelial wound repair in vitro. Am J Physiol 1994;266:C269-275.
13. Takahashi M, Ota S, Hata Y, Ogura K, Terano A, Omata M. Hepatocyte growth factor as a key factor to modulate anti-ulcer action of prostaglandins in gastric mucosa. Gastroenterology 1996;110:A269.